Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) EPS (Weighted Average and Diluted) (2021 - 2025)

Cardio Diagnostics Holdings' EPS (Weighted Average and Diluted) history spans 5 years, with the latest figure at -$0.97 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 43.93% year-over-year to -$0.97; the TTM value through Sep 2025 reached -$2.92, up 68.8%, while the annual FY2024 figure was -$0.31, 53.03% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.97 at Cardio Diagnostics Holdings, roughly flat from -$0.97 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.04 in Q3 2022 and bottomed at -$5.93 in Q1 2024.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.28 (2022), against an average of -$0.88.
  • The largest annual shift saw EPS (Weighted Average and Diluted) skyrocketed 101.3% in 2023 before it plummeted 5382.64% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.12 in 2021, then plummeted by 518.55% to -$0.77 in 2022, then surged by 101.3% to $0.01 in 2023, then plummeted by 200.0% to -$0.01 in 2024, then plummeted by 9600.0% to -$0.97 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's EPS (Weighted Average and Diluted) are -$0.97 (Q3 2025), -$0.97 (Q2 2025), and -$0.97 (Q1 2025).